Cost-effectiveness of lymphadenectomy in patients with early breast cancer luminal type A

Everyone knows that the surgical treatment of breast cancer is a major step in the combined treatment of breast cancer. One of the problems faced by cancer clinics are large economic costs in the treatment of patients with breast cancer. Thereby significantly affect the budget oncology clinics. In turn, the operations for performing advanced breast cancer significantly increases the time of hospital stay and also increases the cost of treating the patient. The objective of our study is to evaluate the cost-effectiveness of different options for surgical treatment in patients with early breast cancer luminal type A. We analyzed 200 patients with stage T1N0M0 breast cancer with luminal type A follow-up was 5 years. Patients were divided into four groups. The first group included 50 patients who underwent mastectomy with preservation of both pectoral muscles. The second group included 50 patients who had undergone radical resection of the breast. The third group included 50 patients who underwent resection of sectoral with stadiuma lymph node dissection. The fourth group included 50 patients who underwent resection with wide sectoral lymph node biopsy signal. As a result, we found that the implementation of sectoral resection with lymph node biopsy signaling in patients with breast cancer T1N0M0 stage (luminal type A) allows to reduce the duration of inpatient treatment and thus reduce the cost of inpatient care at a comparable overall and disease-free survival.

1. Давыдов М.И., Аксель Е.М. Статистика злокачественных новообразований в России и странах СНГ. М., 2010. [Davydov M.I., Axel E.M. Statistics of malignant neoplasms in Russia and CIS countries. Moscow, 2010. (In Russ.)].

2. Чиссов В.И., Старинский В.В., Петрова Г.В. Состояние онкологической помощи населению России в 2011 году. М., 2012. [Chissov V.I., Starinskiy V.V., Petrova G.V. Status of oncology aid to the population of Russia in 2011. Moscow, 2012. (In Russ.)].

3. Дымарский Л.Ю. Рак молочной железы. М.: Медицина, 1980. 192 с. [Dymarskiy L.Yu. Breast cancer. Moscow: Meditsina, 1980. 192 p. (In Russ.)].

4. Вельдшер Л.З., Габуния З.Р., Праздников Э.Н. и др. Пути оптимизации объема лимфодиссекции при раке молочной железы. Вестник Московского онкологического общества 2001;1:2–3. [Weldscher L.Z., Gabuniya Z.R., Prazdnikov E.N. et al. Methods of optimization of the volume of lymph node dissection with breast cancer. Vestnik moskovskogo onkologicheskogo obschestva = Herald of Moscow Oncological Society 2001;1: 2–3. (In Russ.)].

5. Александров М.А. Доказательная медицина и экономический анализ в здравоохранении. Главный врач 2012;3:30–6. [Alexandrov M.A. Evidence based medicine and economic analysis in health care. Glavnyi Vrach = Head Physician 2012;3:30–6. (In Russ.)].

6. Гринхальх Т. Основы доказательной медицины. Пер. с англ. М.: ГЭОТАР-МЕД, 2004. 240 с. [Grinchalch T. Essentials of evidence based medicine. Translation from English. Moscow: GEOTAR-MED, 2004. 240 p. (In Russ.)].